DUOGLOBE : One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease-Reference-Cited by-同舟云学术

DUOGLOBE : One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease

Published:2021-09-12 Issue:7 Volume:8 Page:1061-1074
ISSN:2330-1619
Container-title:Movement Disorders Clinical Practice
language:en
Short-container-title:Mov Disord Clin Pract

Author:

Standaert David G.¹^ORCID,Aldred Jason²,Anca‐Herschkovitsch Marieta³,Bourgeois Paul⁴,Cubo Esther⁵,Davis Thomas L.⁶,Iansek Robert⁷,Kovács Norbert⁸,Pontieri Francesco E.⁹^ORCID,Siddiqui Mustafa S.¹⁰^ORCID,Simu Mihaela¹¹,Bergmann Lars¹²,Kukreja Pavnit¹²,Robieson Weining Z.¹²,Chaudhuri K. Ray¹³^ORCID

Affiliation:

1. University of Alabama at Birmingham Birmingham Alabama USA

2. Selkirk Neurology Spokane Washington USA

3. Edith Wolfson Medical Center Holon Israel

4. Department of Neurology AZ Groeninge Kortrijk Belgium

5. Neurology Department Hospital Universitario Burgos Burgos Spain

6. Vanderbilt University Medical Center Nashville Tennessee USA

7. Kingston Centre, Monash Health Melbourne Victoria Australia

8. University of Pécs Pécs Hungary

9. Sapienza University of Rome Rome Italy

10. Wake Forest School of Medicine Winston Salem North Carolina USA

11. Victor Babes University of Medicine and Pharmacy Timisoara Romania

12. AbbVie Inc North Chicago Illinois USA

13. Parkinson's Foundation Centre of Excellence, King's College Hospital, and King's College Institute of Psychiatry, Psychology & Neuroscience London United Kingdom

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mdc3.13239

Reference48 articles.

1. Oral and Infusion Levodopa-Based Strategies for Managing Motor Complications in Patients with Parkinsonʼs Disease

2. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients

3. Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?

4. Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features

5. Systematic review on factors associated with medication non-adherence in Parkinson's disease

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monotherapy with infusion therapies – useful or not?;Journal of Neural Transmission;2024-07-05

2. Effects of Continuous Dopaminergic Stimulation on Parkinson’s Disease Gait: A Longitudinal Prospective Study with Levodopa Intestinal Gel Infusion;Journal of Parkinson's Disease;2024-06-04

3. Levodopa infusion therapies for Parkinson disease;Current Opinion in Neurology;2024-05-23

4. Levodopa-carbidopa intestinal gel infusion in Parkinson's disease;International Review of Movement Disorders;2024

5. Therapieansätze für das fortgeschrittene idiopathische Parkinson-Syndrom;DNP – Die Neurologie & Psychiatrie;2023-12